Clingen is revolutionizing cancer diagnosis through genetic testing and biomarker identification. By identifying specific genetic mutations associated with different types of cancer, healthcare providers can diagnose the disease more accurately. Tests like Next-Generation Sequencing (NGS) allow for the comprehensive analysis of multiple genes at once, leading to quicker and more precise diagnoses.
